BINDING OF SOLUBLE IMMUNE COMPLEXES TO HUMAN LYMPHOBLASTOID CELLS

In the present work we studied the expression of membrane-bound Ig (MBIg) as well as receptors for IgG Fc and complement on nine human lymphoblastoid cell lines. When MBIg and receptors for IgG Fc were compared, four categories of cell lines could be distinguished: (a) cell lines having both MBIg and receptors for IgG Fc, (b) cell lines having MBIg but lacking receptors for IgG Fc, (c) cell lines lacking MBIg but having receptors for IgG Fc, and (d) cell lines lacking both MBIg and receptors for IgG Fc. Two types of receptors for complement could be detected on the cell lines studied, one for C3-C3b and one for C3d. When sensitized red cells carrying C3b or C3d were used for rosette tests, three categories of cell lines could be distinguished: (a) cell lines having receptors for C3b and C3d, (b) cell lines having receptors only for C3d and (c) cell lines lacking both receptors. However, when a more sensitive immunofluorescent method was used instead of the rosette technique, it was found that cell lines unable to form rosettes with EAC1423bhu were able to bind soluble C3 or C3b which indicated the presence of these receptors on the cell surface. Inhibition experiments showed that receptors for C3-C3b and receptors for C3d are distinct and that receptors for C3-C3b and C3d are different from receptors for IgG Fc. A cell line (Raji) without MBIg but with receptors for IgG Fc, C3-C3b, and C3d was selected for use in studying the binding mechanism of soluble immune complexes to cell surface membrane. Aggregated human gamma globulin was used in place of immune complexes. Immune complexes containing complement bind to Raji cells only via receptors for complement, namely receptors for C3-C3b and C3d. Binding of immune complexes containing complement to cells is much greater than that of complexes without complement. Immune complexes bound to cells via receptors for complement can be partially released from the cell surface by addition of normal human serum as well as isolated human C3 or C3b. We postulate that such release is due to competition of immune complex bound C3b and free C3 or C3b for the receptors on Raji cells.

[1]  S. Ferrone,et al.  Evaluation of C3 receptors on lymphoid cells with different complement sources. , 1974, Journal of immunology.

[2]  A. Theofilopoulos,et al.  RECEPTOR FOR SOLUBLE C3 AND C3b ON HUMAN LYMPHOBLASTOID (RAJI) CELLS , 1974, The Journal of experimental medicine.

[3]  R. Gilbertsen,et al.  Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. , 1974, Journal of immunology.

[4]  G. Miller,et al.  Human lymphocytes bear membrane receptors for C3b and C3d. , 1973, The Journal of clinical investigation.

[5]  H. Grey,et al.  TWO DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTES , 1973, The Journal of experimental medicine.

[6]  G. Miller,et al.  COMPLEMENT-DEPENDENT RELEASE OF IMMUNE COMPLEXES FROM THE LYMPHOCYTE MEMBRANE , 1973, The Journal of experimental medicine.

[7]  Z. Bentwich,et al.  Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. , 1973, Clinical immunology and immunopathology.

[8]  C. Bianco,et al.  Mechanism of binding of soluble immune complexes to lymphocytes. , 1973, Cellular immunology.

[9]  Z. Bentwich,et al.  Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. , 1973, Clinical and experimental immunology.

[10]  H. Grey,et al.  Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. , 1973, The Journal of clinical investigation.

[11]  V. Nussenzweig,et al.  Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. , 1972, Blood.

[12]  H. Wigzell,et al.  SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES , 1972, The Journal of experimental medicine.

[13]  E. Shevach,et al.  Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines. , 1972, The Journal of clinical investigation.

[14]  H. Kunkel,et al.  INTERACTION OF AGGREGATED γ-GLOBULIN WITH B LYMPHOCYTES , 1972, The Journal of experimental medicine.

[15]  S. Ruddy,et al.  C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. , 1971, Journal of immunology.

[16]  R. Lerner,et al.  Gene expression in synchronized lymphocytes: Studies on the control of synthesis of immunoglobulin polypeptides , 1971, Journal of cellular physiology.

[17]  K. Hirschhorn,et al.  Products of lymphoid cells in continuous culture. , 1970, The American journal of pathology.

[18]  H. Müller-Eberhard,et al.  ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM , 1969, The Journal of experimental medicine.

[19]  M. Polley,et al.  Human Monocytes: Distinct Receptor Sites for the Third Component of Complement and for Immunoglobulin G , 1968, Science.

[20]  V. Nussenzweig,et al.  RECEPTORS FOR COMPLEMENT ON LEUKOCYTES , 1968, The Journal of experimental medicine.

[21]  J. Levy,et al.  Human lymphoblastoid lines from lymph node and spleen , 1968, Cancer.

[22]  George,et al.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. , 1968, Cancer research.

[23]  J. Fahey,et al.  Synthesis of immunoglobulins by human cell lines in tissue culture. , 1967, Journal of immunology.

[24]  H. Müller-Eberhard,et al.  DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECT , 1967, The Journal of experimental medicine.

[25]  G. Uhlenbruck,et al.  Studies on the Nature of the Immune Adherence Receptor , 1967 .

[26]  H. Müller-Eberhard,et al.  DEFICIENCY OF THE SIXTH COMPONENT OF COMPLEMENT IN RABBITS WITH AN INHERITED COMPLEMENT DEFECT , 1966, The Journal of experimental medicine.

[27]  F. Dixon,et al.  A method of trace iodination of proteins for immunologic studies. , 1966, International archives of allergy and applied immunology.

[28]  H. Müller-Eberhard,et al.  ISOLATION OF β1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT , 1965, The Journal of experimental medicine.

[29]  M. Mardiney,et al.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. , 1965, Journal of immunology.

[30]  R. Pulvertaft A study of malignant tumours in Nigeria by short-term tissue culture , 1965, Journal of clinical pathology.

[31]  C. Shepard,et al.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY. , 1963, Virology.

[32]  K. Ishizaka Gamma globulin and molecular mechanisms in hypersensitivity reactions. , 1963, Progress in allergy.

[33]  C. Christian Studies of aggregated gamma-globulin. I. Sedimentation, electrophoretic and anticomplementary properties. , 1960, Journal of immunology.

[34]  P. Verschueren,et al.  TWO DIFFERENT , 2022 .